Medical Sale Purchase Of Stock vs Change In Cash Analysis

MPW Stock

USD 4.11 0.01 0.24%

Medical Properties financial indicator trend analysis is infinitely more than just investigating Medical Properties Trust recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medical Properties Trust is a good investment. Please check the relationship between Medical Properties Sale Purchase Of Stock and its Change In Cash accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Sale Purchase Of Stock vs Change In Cash

Sale Purchase Of Stock vs Change In Cash Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medical Properties Trust Sale Purchase Of Stock account and Change In Cash. At this time, the significance of the direction appears to have no relationship.

The correlation between Medical Properties' Sale Purchase Of Stock and Change In Cash is 0.0. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Change In Cash in the same time period over historical financial statements of Medical Properties Trust, assuming nothing else is changed. The correlation between historical values of Medical Properties' Sale Purchase Of Stock and Change In Cash is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Medical Properties Trust are associated (or correlated) with its Change In Cash. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Change In Cash has no effect on the direction of Sale Purchase Of Stock i.e., Medical Properties' Sale Purchase Of Stock and Change In Cash go up and down completely randomly.

Correlation Coefficient

0.0

Relationship Direction	Flat
Relationship Strength	Insignificant

View All Relationships

Sale Purchase Of Stock

Change In Cash

Most indicators from Medical Properties' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medical Properties Trust current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medical Properties Trust. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

At this time, Medical Properties' Selling General Administrative is fairly stable compared to the past year. Enterprise Value Over EBITDA is likely to climb to 21.16 in 2024, despite the fact that Tax Provision is likely to grow to (113.4 M).

	2021	2022	2023	2024 (projected)
Gross Profit	1.5B	1.5B	830.2M	537.8M
Total Revenue	1.5B	1.5B	871.8M	549.6M

Gross Profit Total Revenue

Medical Properties fundamental ratios Correlations

	Total Assets	Accounts Payable	Cash	Other Assets	Total Liab	Common Stock	Short Long Term Debt Total	Total Stockholder Equity	Other Liab	Property Plant And Equipment Net	Net Debt	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Long Term Debt	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Stockholder Equity	Property Plant And Equipment Gross	Total Current Assets	Other Current Liab	Total Current Liabilities	Current Deferred Revenue
Total Assets		0.63	0.43	0.43	1.0	0.98	0.99	0.99	0.66	0.35	0.99	-0.15	1.0	0.07	0.99	0.42	0.82	0.98	0.99	0.99	1.0	0.32	0.87	-0.1	0.71	0.37
Accounts Payable	0.63		0.15	0.3	0.62	0.56	0.58	0.64	0.47	0.39	0.63	0.1	0.62	-0.13	0.61	0.16	0.63	0.58	0.6	0.61	0.62	-0.05	0.6	-0.19	0.53	-0.02
Cash	0.43	0.15		0.27	0.38	0.48	0.35	0.5	0.19	-0.08	0.29	0.4	0.41	0.28	0.41	1.0	0.42	0.43	0.41	0.41	0.46	0.22	0.72	-0.03	0.03	0.23
Other Assets	0.43	0.3	0.27		0.42	0.41	0.4	0.43	0.79	-0.11	0.4	0.14	0.43	0.32	0.46	0.26	0.57	0.37	0.42	0.46	0.42	0.14	0.51	-0.2	0.08	0.15
Total Liab	1.0	0.62	0.38	0.42		0.97	0.99	0.98	0.68	0.34	0.99	-0.19	1.0	0.07	0.99	0.36	0.82	0.97	0.99	0.99	0.99	0.3	0.85	-0.11	0.73	0.36
Common Stock	0.98	0.56	0.48	0.41	0.97		0.96	0.99	0.61	0.3	0.96	-0.19	0.98	0.11	0.97	0.46	0.75	0.99	0.99	0.97	0.99	0.4	0.85	-0.01	0.71	0.46
Short Long Term Debt Total	0.99	0.58	0.35	0.4	0.99	0.96		0.97	0.69	0.36	0.99	-0.17	0.99	0.06	0.99	0.33	0.83	0.95	0.97	0.99	0.97	0.31	0.84	-0.18	0.69	0.36
Total Stockholder Equity	0.99	0.64	0.5	0.43	0.98	0.99	0.97		0.63	0.36	0.96	-0.08	0.99	0.05	0.98	0.49	0.81	0.98	0.98	0.98	0.99	0.31	0.89	-0.09	0.67	0.36
Other Liab	0.66	0.47	0.19	0.79	0.68	0.61	0.69	0.63		0.01	0.66	0.04	0.66	0.31	0.71	0.17	0.86	0.57	0.63	0.71	0.62	0.35	0.69	-0.52	0.24	0.34
Property Plant And Equipment Net	0.35	0.39	-0.08	-0.11	0.34	0.3	0.36	0.36	0.01		0.41	0.3	0.39	-0.91	0.37	-0.08	0.29	0.27	0.33	0.37	0.32	0.07	0.15	-0.26	0.08	0.07
Net Debt	0.99	0.63	0.29	0.4	0.99	0.96	0.99	0.96	0.66	0.41		-0.22	0.99	0.0	0.99	0.27	0.8	0.96	0.98	0.99	0.97	0.29	0.8	-0.12	0.74	0.35
Retained Earnings	-0.15	0.1	0.4	0.14	-0.19	-0.19	-0.17	-0.08	0.04	0.3	-0.22		-0.13	-0.37	-0.09	0.42	0.24	-0.28	-0.21	-0.1	-0.18	-0.17	0.18	-0.63	-0.69	-0.22
Non Current Assets Total	1.0	0.62	0.41	0.43	1.0	0.98	0.99	0.99	0.66	0.39	0.99	-0.13		0.02	0.99	0.39	0.82	0.97	0.99	0.99	0.99	0.32	0.86	-0.13	0.69	0.38
Non Currrent Assets Other	0.07	-0.13	0.28	0.32	0.07	0.11	0.06	0.05	0.31	-0.91	0.0	-0.37	0.02		0.05	0.28	0.08	0.14	0.08	0.05	0.09	0.08	0.24	0.19	0.2	0.11
Long Term Debt	0.99	0.61	0.41	0.46	0.99	0.97	0.99	0.98	0.71	0.37	0.99	-0.09	0.99	0.05		0.4	0.86	0.95	0.97	1.0	0.98	0.32	0.88	-0.2	0.64	0.36
Cash And Short Term Investments	0.42	0.16	1.0	0.26	0.36	0.46	0.33	0.49	0.17	-0.08	0.27	0.42	0.39	0.28	0.4		0.41	0.42	0.39	0.4	0.44	0.16	0.72	-0.03	0.03	0.17
Net Receivables	0.82	0.63	0.42	0.57	0.82	0.75	0.83	0.81	0.86	0.29	0.8	0.24	0.82	0.08	0.86	0.41		0.7	0.75	0.86	0.78	0.25	0.9	-0.6	0.28	0.23
Common Stock Total Equity	0.98	0.58	0.43	0.37	0.97	0.99	0.95	0.98	0.57	0.27	0.96	-0.28	0.97	0.14	0.95	0.42	0.7		0.99	0.95	0.99	0.36	0.82	0.08	0.79	0.42
Common Stock Shares Outstanding	0.99	0.6	0.41	0.42	0.99	0.99	0.97	0.98	0.63	0.33	0.98	-0.21	0.99	0.08	0.97	0.39	0.75	0.99		0.97	0.99	0.37	0.83	-0.02	0.74	0.43
Non Current Liabilities Total	0.99	0.61	0.41	0.46	0.99	0.97	0.99	0.98	0.71	0.37	0.99	-0.1	0.99	0.05	1.0	0.4	0.86	0.95	0.97		0.98	0.31	0.88	-0.2	0.65	0.36
Other Stockholder Equity	1.0	0.62	0.46	0.42	0.99	0.99	0.97	0.99	0.62	0.32	0.97	-0.18	0.99	0.09	0.98	0.44	0.78	0.99	0.99	0.98		0.33	0.86	-0.03	0.73	0.38
Property Plant And Equipment Gross	0.32	-0.05	0.22	0.14	0.3	0.4	0.31	0.31	0.35	0.07	0.29	-0.17	0.32	0.08	0.32	0.16	0.25	0.36	0.37	0.31	0.33		0.24	-0.02	0.12	0.95
Total Current Assets	0.87	0.6	0.72	0.51	0.85	0.85	0.84	0.89	0.69	0.15	0.8	0.18	0.86	0.24	0.88	0.72	0.9	0.82	0.83	0.88	0.86	0.24		-0.3	0.43	0.26
Other Current Liab	-0.1	-0.19	-0.03	-0.2	-0.11	-0.01	-0.18	-0.09	-0.52	-0.26	-0.12	-0.63	-0.13	0.19	-0.2	-0.03	-0.6	0.08	-0.02	-0.2	-0.03	-0.02	-0.3		0.46	0.02
Total Current Liabilities	0.71	0.53	0.03	0.08	0.73	0.71	0.69	0.67	0.24	0.08	0.74	-0.69	0.69	0.2	0.64	0.03	0.28	0.79	0.74	0.65	0.73	0.12	0.43	0.46		0.2
Current Deferred Revenue	0.37	-0.02	0.23	0.15	0.36	0.46	0.36	0.36	0.34	0.07	0.35	-0.22	0.38	0.11	0.36	0.17	0.23	0.42	0.43	0.36	0.38	0.95	0.26	0.02	0.2

Click cells to compare fundamentals

Medical Properties Account Relationship Matchups

Medical Properties fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	14.5B	16.8B	20.5B	19.7B	18.3B	19.2B
Accounts Payable	(107.9M)	387.5M	603.6M	621.3M	412.2M	432.8M
Cash	1.5B	549.9M	459.2M	235.7M	250.0M	258.7M
Other Assets	1.5B	15.0B	3.9B	632.6M	1.3B	1.5B
Total Liab	7.4B	9.5B	12.1B	11.1B	10.7B	11.2B
Common Stock	371K	518K	541K	597K	599K	629.0K
Short Long Term Debt Total	7.1B	9.0B	12.9B	11.3B	10.2B	10.7B
Total Stockholder Equity	7.0B	7.3B	8.4B	8.6B	7.6B	8.0B
Other Liab	45.7M	180.9M	183.6M	70.3M	80.9M	61.7M
Net Debt	5.7B	8.5B	11.0B	11.1B	9.9B	10.4B
Retained Earnings	83.0M	(71.4M)	(87.7M)	116.3M	(971.8M)	(923.2M)
Non Current Assets Total	12.1B	14.9B	17.9B	18.2B	15.7B	16.4B
Non Currrent Assets Other	10.5B	12.5B	15.3B	(32.1B)	11.4B	11.9B
Long Term Debt	7.0B	8.9B	11.3B	10.3B	8.5B	9.0B
Cash And Short Term Investments	1.5B	549.9M	459.2M	235.7M	250.0M	271.7M
Net Receivables	910.4M	1.4B	2.1B	1.2B	681.0M	424.2M
Common Stock Total Equity	371K	518K	541K	597K	686.6K	720.9K
Common Stock Shares Outstanding	428.3M	530.5M	590.1M	598.8M	598.5M	628.4M
Liabilities And Stockholders Equity	14.5B	16.8B	20.5B	19.7B	18.3B	19.2B
Non Current Liabilities Total	7.1B	9.0B	11.4B	10.4B	8.7B	9.1B
Other Stockholder Equity	7.0B	7.5B	8.7B	8.5B	8.6B	9.0B
Total Current Assets	2.4B	1.9B	2.6B	1.4B	1.4B	1.3B
Accumulated Other Comprehensive Income	(62.9M)	(51.3M)	(36.7M)	(59.2M)	42.5M	44.6M
Other Current Liab	291.5M	(114.1M)	(1.6B)	(483.3M)	1.1B	1.1B
Total Current Liabilities	307.6M	474.9M	633.4M	649.1M	2.0B	2.1B
Current Deferred Revenue	16.1M	36.2M	25.6M	27.7M	38.0M	36.1M
Other Current Assets	(1.8B)	(1.1B)	(1.2B)	304.5M	442.1M	420.0M
Short Term Debt	107.9M	165.4M	1.6B	483.3M	463.1M	534.4M
Intangible Assets	622.1M	1.3B	1.4B	1.4B	1.0B	983.1M
Inventory	1.8B	1.0	1.2B	(304.5M)	(149.5M)	(142.0M)
Net Tangible Assets	6.4B	6.0B	8.4B	7.2B	8.3B	4.3B
Noncontrolling Interest In Consolidated Entity	107K	5.3M	5.5M	1.6M	1.4M	1.3M
Retained Earnings Total Equity	83.0M	(71.4M)	(87.7M)	116.3M	104.7M	109.9M
Long Term Debt Total	7.0B	8.9B	11.3B	10.3B	11.8B	12.4B
Capital Surpluse	7.0B	7.5B	8.6B	8.5B	9.8B	5.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
GM	General Motors
F	Ford Motor

Additional Tools for Medical Stock Analysis

When running Medical Properties' price analysis, check to measure Medical Properties' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medical Properties is operating at the current time. Most of Medical Properties' value examination focuses on studying past and present price action to predict the probability of Medical Properties' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medical Properties' price. Additionally, you may evaluate how the addition of Medical Properties to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Medical Sale Purchase Of Stock vs Change In Cash Analysis

Sale Purchase Of Stock vs Change In Cash

Sale Purchase Of Stock vs Change In Cash Correlation Analysis

Correlation Coefficient

Sale Purchase Of Stock

Change In Cash

Medical Properties fundamental ratios Correlations

Medical Properties Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Medical Properties fundamental ratios Accounts

Also Currently Popular

Additional Tools for Medical Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Non Current Assets Total	+ 1.0	Total Liab
Non Current Liabilities Total	+ 1.0	Long Term Debt

Non Currrent Assets Other	- 0.91	Property Plant And Equipment Net
Total Current Liabilities	- 0.69	Retained Earnings
Other Current Liab	- 0.63	Retained Earnings
Other Current Liab	- 0.6	Net Receivables
Other Current Liab	- 0.52	Other Liab
Non Currrent Assets Other	- 0.37	Retained Earnings